Increased research and development activities, rapid increase in genetic testing, and favorable reimbursement policies regarding medical testing are key factors that are expected to drive the market growth
According to Emergen Research, the global reproductive genetics market size was $ 4.41 billion in 2020 and is expected to reach $ 11.23 billion in 2028 and register a revenue CAGR of 12.3% during the forecast period, 2021-2028.
Reproductive genetics deals with the relationship between reproduction and genotype. This includes research into how genetic material and epigenetic alterations are passed down from generation to generation during pregnancy. It refers to genetic tests and procedures that provide information regarding the possibility that parents pass a genetic mutation to their offspring; identification of the causes of infertility and information on the genetic characteristics of embryos produced by IVF. This information helps individuals make informed decisions about medical and lifestyle decisions, and assess the risks of common chromosomal disorders. These key factors are expected to drive the market revenue growth over the forecast period.
Claim your FREE copy with table of contents @ https://www.emergenresearch.com/request-sample/695
In addition, the growing awareness of genetic testing and screening along with technical improvements are expected to further fuel the market revenue growth. In addition, increasing government and private investments in advancements in genomic technologies to support the diagnosis of genetic disorders and early identification of the causes of infertility are major factors that are expected to drive the market growth during the period. forecast.
However, high cost of testing, improper treatment, lack of regulation and sequelae of reproductive genetics testing may hamper the market growth to some extent during the forecast period. For example, testing increases stress and anxiety in some people and negatively impacts personal and family relationships.
COVID-19 impact assessment
- Social distancing and restrictions have severely disrupted businesses and operations
- The closures have caused disruption in transportation and logistics
- Global Manufacturing and Mining Operations Affected
- Took a toll on the economy of various countries
- Caused a sudden and drastic slowdown in economic activity
- Agriculture, fishing, dairy and other disrupted sectors
- Caused job loss and financial crisis
- The impacts on supply have worsened further due to the drop in disposable income
- The emergence of variants continues to cause concern and impact normal routines
In situ hybridization segment sales will grow at a rapid CAGR:
In situ hybridization segment is expected to register a rapid revenue CAGR over the forecast period, attributed to increasing number of patients with genetic disorders and cancer and increased awareness of companion diagnostic tests in hybridization. in situ (ISH).
Check our prices @ https://www.emergenresearch.com/select-license/695
Monogenic Disorders Segment Records Significant Revenue Growth:
Monogenic Disorders segment is expected to register significant revenue growth during the forecast period. Due to their inherited patterns and relatively simple genetic causes, monogenic diseases are among the best understood genetic disorders. Cystic fibrosis, sickle cell anemia, hemochromatosis and Tay-Sachs disease are some of the most common monogenic diseases. Monogenic disorders in infants can be detected by genetic reproduction tests.
North America will account for the largest share of revenue:
North America is expected to account for the largest share of the global market revenue during the forecast period owing to the rapid adoption of genomics techniques, advanced healthcare infrastructure, and the presence of key market players in the region. In addition, the increasing use of in vitro fertilization (IVF) procedures along with technological advancements are also expected to fuel the revenue growth of the North American market.
The main companies in the market include:
- Illumina, Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Quest Diagnosis
- Thermo Fisher Scientific Inc.
- Fulgent Genetics, Inc.
- Centogene SA
- Myriad Genetics, Inc.
- Qiagen SA
- OPKO Health, Inc.
For the purpose of this report, Emergen Research has segmented the global Reproductive Genetics market on the basis of Product Type, Procedure Type, Technology, Application, and Region:
Product Type Outlook (Revenue, USD Billion; 2018-2028)
- Laboratory-developed tests (LDT)
- Pencil cases
- Reagents and consumables
Outlook Procedure Type (Revenue, USD Billion; 2018-2028)
- Prenatal screening
- Preimplantation genetic tests
- Genetic infertility tests
- Carrier screening
Technology Outlook (Revenue, USD Billion; 2018-2028)
- Next Generation Sequencing (NGS)
- Polymerase chain reaction (PCR)
- In-Situ Hybridization (ISH)
Application Outlook (Revenue, USD Billion; 2018-2028)
- Monogenic disorder
- Structural chromosome abnormality
Click to access the study of the report, read the highlights of the report and view the projected trends: https://www.emergenresearch.com/industry-report/reproductive-genetics-market
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- The rest of europe
- Asia Pacific
- South Korea
- Rest of the APAC
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of the MEA
Take a look at our related reports:
Self-refractor market Analysis by product type (retinoscopes, OCT scanners, corneal topography systems, ophthalmoscopes, others), by application (myopia, hyperopia, others), by end user (hospitals, eye clinics, diagnostic centers), by region, forecast up to ‘in 2027
Drug Discovery Services Market Analysis by process (target selection, target validation, lead optimization, candidate validation, others), by type (medicinal chemistry, biology services, pharmacokinetics and drug metabolism), by drug type (biologics , small molecules), by therapeutic area (neurology, Diabetes, oncology, others), by end user (hospitals and clinics, pharmaceutical and biotechnology companies, others), by region, forecast to 2027
Wound Cleaning Products Market By type of product (wetting agents, antiseptics, moisturizers, others), by type of form (sprays, solutions, wipes, foams, others), by end user (hospitals, outpatient surgery centers, pharmacies and clinics, healthcare establishments home) and by region in 2027
Flexible Sigmoidoscopy Market Analysis by product type (flexible sigmoidoscope, rigid sigmoidoscope), by application (monitoring, diagnosis, others), by end user (hospitals, clinics, diagnostic centers, outpatient surgery centers, gastroenterology institutes, others), by region, forecast until 2027
Hydralazine market Analysis by type (tablet, injection), by application (hospital, clinics, diagnostic centers, recovery centers, others), by end use, by region, forecast to 2027
About Emergen Recherche
Emergen Research is a market research and consulting firm that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics and industries, and helping customers make smarter business decisions. We offer market intelligence studies ensuring relevant and evidence-based research across multiple industries including healthcare, touchpoints, chemicals, types, and energy. We are constantly updating our research offerings to ensure that our clients are up to date with the latest trends that exist in the market. Emergen Research has a solid base of experienced analysts from various fields of expertise. Our industry experience and our ability to develop a practical solution to any research problem gives our clients the opportunity to gain an edge over their respective competitors.
Business Sales Specialist
Emerging research | The Web: www.emergenresearch.com
Direct line: +1 (604) 757-9756
Email: [email protected]
Read the full press release: https://www.emergenresearch.com/press-release/global-reproductive-genetics-market